GlassScriptPhysician profile
Kimberly L Maino
NPI 1588664130
$3,278.63
in general payments reported to CMS, 2019-2025
25 companies · $529 in 2025
The $529 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.39 · 2020: $113 · 2021: $426 · 2022: $658 · 2023: $772 · 2024: $757 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,942 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,941.82 |
| Education | $115.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $532.89 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Abbvie INC. | $303.65 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $290.73 | 2021-2025 | Winlevi, Blu-U, Odomzo |
| Regeneron Healthcare Solutions, INC. | $281.80 | 2021-2025 | Libtayo, Dupixent |
| Genzyme Corporation | $253.28 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $243.49 | 2020-2025 | |
| Pfizer INC. | $194.29 | 2020-2024 | |
| Ucb, INC. | $165.41 | 2021-2025 | Bimzelx, Cimzia |
| Amgen INC. | $161.48 | 2019-2025 | Otezla, Otezla |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $157.35 | 2023 | |
| Almirall LLC | $125.97 | 2022-2024 | Seysara, Klisyri |
| Incyte Corporation | $115.52 | 2021-2025 | Opzelura |
| Arcutis Biotherapeutics, INC. | $83.92 | 2025 | Zoryve |
| Lilly USA, LLC | $64.64 | 2020-2025 | Taltz, Ebglyss, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $61.33 | 2023 | Sotyktu |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $52.36 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Biofrontera INC. | $50.24 | 2021-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Merz North America, INC. | $23.01 | 2022 | |
| Smith+Nephew, INC. | $22.41 | 2023 | Grafix Pl |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.77 | 2021 | |
| Paratek Pharmaceuticals, INC. | $19.35 | 2022 | |
| Leo Pharma INC. | $17.88 | 2022 | |
| Organogenesis INC. | $12.79 | 2021 | |
| Bioventus LLC | $12.52 | 2022 | |
| Misonix INC | $11.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Maino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.